Literature DB >> 19162116

Hepatitis A vaccination coverage among adults aged 18-49 years in the United States.

Peng-jun Lu1, Gary L Euler, Karen A Hennessey, Cindy M Weinbaum.   

Abstract

BACKGROUND: Hepatitis A is the most common type of hepatitis reported in the United States. Prior to hepatitis A vaccine introduction in 1996, hepatitis A incidence followed a cyclic pattern with peak incidence occurring every 10-15 years. During 1980-1995, between 22,000 and 36,000 hepatitis A cases were reported annually. Since 1996, hepatitis A vaccination recommendations have included adults at risk for infection and children living in communities with the highest disease rates. This study provides the first national estimates of self-reported hepatitis A vaccination coverage among persons aged 18-49 years in the United States.
METHODS: We analyzed the 2007 National Immunization Survey-Adult (NIS-Adult) data with restrictions to individuals aged 18-49 years. National estimates of hepatitis A vaccination coverage were calculated based on self-report and multivariable logistic regression analysis was used to identify factors independently associated with hepatitis A vaccination status.
RESULTS: Among adults aged 18-49 years, 12.1% (95% confidence interval, CI=9.9-14.8%) had received two or more doses of hepatitis A vaccine in 2007. Hepatitis A vaccination coverage was significantly higher among adults aged 18-29 years (15.6%) and adults aged 30-39 years (12.9%) compared with adults aged 40-49 years (8.3%). Coverage was significantly lower for Hispanics (7.1%) compared with non-Hispanic whites (12.5%). Characteristics independently associated with a higher likelihood of hepatitis A vaccination among persons aged 18-49 years included younger age groups, persons at or above poverty level, persons with public medical insurance, and persons who received influenza vaccination in the past season.
CONCLUSIONS: In 2007, self-reported hepatitis A vaccination coverage among adults aged 18-49 years was 12.1%. These data provide the first national hepatitis A vaccination coverage estimates among adults and are very important in planning and implementing strategies for increasing hepatitis A vaccination coverage among adults at risk for hepatitis A.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19162116     DOI: 10.1016/j.vaccine.2008.12.054

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  Highlights of historical events leading to national surveillance of vaccination coverage in the United States.

Authors:  Philip J Smith; David Wood; Paul M Darden
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

2.  Seroprevalence of hepatitis A virus antibodies in the U.S.: results from the National Health and Nutrition Examination Survey.

Authors:  R Monina Klevens; Deanna Kruszon-Moran; Annemarie Wasley; Kathleen Gallagher; Geraldine M McQuillan; Wendi Kuhnert; Eyasu H Teshale; Jan Drobeniuc; Beth P Bell
Journal:  Public Health Rep       Date:  2011 Jul-Aug       Impact factor: 2.792

3.  Human papillomavirus vaccine initiation and awareness: U.S. young men in the 2010 National Health Interview Survey.

Authors:  Peng-Jun Lu; Walter W Williams; Jun Li; Christina Dorell; David Yankey; Deanna Kepka; Eileen F Dunne
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

4.  Knowledge of viral hepatitis among Puerto Rican adults: implications for prevention.

Authors:  Marievelisse Soto-Salgado; Erick Suárez; Ana P Ortiz; Sandra Adrovet; Edmir Marrero; Marytere Meléndez; Héctor M Colón; Carmen Albizu; María Del C Santos; Esther Torres; Cynthia M Pérez
Journal:  J Community Health       Date:  2011-08

5.  Public acceptance and willingness to hepatitis a vaccination in children aged 7-18 years in Republic of Korea.

Authors:  Kyoung Ae Kong; Seo Hee Yoon; Su Jin Cho; Han Wool Kim; Kyung-Hyo Kim
Journal:  J Korean Med Sci       Date:  2014-11-04       Impact factor: 2.153

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.